Cuihan Zhou, PhD

Dr. Cuihan Zhou is a Postdoctoral Researcher in Chemistry at Thryv Therapeutics, where she plays a key role in the design and synthesis of a novel library of SGK1 inhibitors.

Dr. Zhou completed her PhD in Organometallics and Organic Synthesis at McGill University, where her research focused on visible-light-induced palladium-catalyzed carbonylation for the synthesis of pharmaceutical-related compounds. During that time, she also developed carbon isotope labelling methods for carboxylic acids in drug molecules for ADME studies